Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Palivizumab for preventing serious lower respiratory tract disease caused by respiratory syncytial virus
Drug guidance

Palivizumab for preventing serious lower respiratory tract disease caused by respiratory syncytial virus

Respiratory

Infections

8 February 2023

Guidance Recommendations

Back to top